Natural history, clinical evolution, and the host-parasite interaction in new world cutaneous leishmaniasis

Clinics in Dermatology

Volumn 14, Issue 5, 1996, Pages 433-450

  Weigle, Kristen ^b   Saravia, Nancy Gore ^a  

^a Ctro Internacional de E   (Colombia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL EXAMINATION; DISEASE COURSE; HISTOPATHOLOGY; HISTORY; HOST PARASITE INTERACTION; HUMAN; LEISHMANIA MEXICANA; PATHOGENESIS; PRIORITY JOURNAL; RECURRENT INFECTION; REVIEW; SKIN LEISHMANIASIS;

EID: 0009833932     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0738-081X(96)00036-3     Document Type: Article

References (161)

1. 1. Grimaldi G, Tesh RB, McMahon-Pratt D. A review of the geographic distribution and epidemiology of leishamaniasis in the New World. Am J Trop Med Hyg 1989;41: 687-725.
2. 2. Anonymous. Control of the Leishmaniasis. Geneva: World Health Organization, Technical Report Series 793, 1990.
3. 3. Escobar MA, Smith DS, Palma GI. American cutaneous and mucocutaneous leishmaniasis (tegumentary): A diagnostic challenge. Trop Doctor 1992;22(suppl 1):69-78.
4. 4. Armijos RX, Chico ME, Cruz ME, et al. Human cutaneous leishmaniasis in Ecuador: Identification of parasites by enzyme electrophoresis. Am J Trop Med Hyg 1990; 42:424-428.
5. 5. Santrich C, Segura I, Arias AL, et al. Mucosal disease caused by Leishmania braziliensis guyanesis. Am J Trop Med Hyg 1990;42:51-55.
6. 6. Sampaio RN, Marsden PD, Llanos-Cuentas EA, et al. Leishmania mexicana amazonensis isolated from a patient with fatal mucosal leishmaniasis. Rev Soc Brasil Med Trop 1985;18:273-274.
7. 7. Velasco O, Savarino SJ, Walton BC, et al. Diffuse cutaneous leishmaniasis in Mexico. Am J Trop Med Hyg 1989; 41:280-288.
8. 8. Barral A, Pedral-Sampaio D, Grimaldi Jr. G, et al. Leishmaniasis in Bahia, Brazil: Evidence that Leishmania amazonensis produces a wide spectrum of clinical disease. Am J Trop Med Hyg 1991;44:536-546.
9. 9. Silveira FT, Lainson R, Shaw JJ, et al. Cutaneous leishmaniasis due to Leishmania (Leishmania) amazonensis in Amazonian Brazil, and the significance of a negative Montenegro skin-test in human infections. Trans R Soc Trop Med Hyg 1991;85:735-738.
10. 10. Herwaldt BL, Arana BA, Navin TR. The natural history of cutaneous leishmaniasis in Guatemala. J Infect Dis 1992;165:518-527.
11. 11. Biagi F. Sintesis de 70 historias clinicas de leishmaniasis tegumentaria de Mexico (ulcera de los chicleros). Medicine (Mexico City) 1953:33:385-396.
12. 12. Llanos-Cuentas EA, Arana M, Cuba-Cuba CA, et al. Leishmaniasis cutanea diseminada asociada a metastasis en mucosas, causada por Leishmania braziliensis braziliensis: Fracaso en el hallazgo de parasitos circulantes. Rev Soc Brasil Med Trop 1985;18:271-272.
13. 13. Barral A, Badaro R, Barral-Neto M, et al. Isolation of Leishmania mexicana amazonensis from the bone-marrow in a case of American visceral leishmaniasis. Am J Trop Med Hyg 1986;35:732-734.
14. 14. Melby PC, Kreutzer RD, McMahon-Pratt D, et al. Cutaneous leishmaniasis: Review of 59 cases seen in the National Institutes of Health. Clin Infec Dis 1992;15:924-927.
15. 15. Ashford RW, Desjeux P, deRaadt P. Estimation of population at risk of infection and number of cases of leishmaniasis. Parasitology Today 1992;8:104-105.
16. 16. Furner BB. Cutaneous leishmaniasis in Texas: Report of a case and review of the literature. J Am Acad Dermatol 1990;23:368-371.
17. 17. Herwaldt BL, Stokes SL, Juranek D. American cutaneous leishmaniasis in US travelers. An Int Med 1993;188:779-784.
18. 18. Weigle KA, Santrich C, Martinez F, et al. Epidemiology of cutaneous leishmaniasis in Colombia: A longitudinal study of the natural history, prevalence, and incidence of infection and clinical manifestations. J Infect Dis 1993; 168:699-708.
19. 19. de Resell RA, de Jesus de Duran R, Rossell O, et al. Is leishmaniasis ever cured? Trans Royal Soc Trop Med Hyg 1992;86:251-253.
20. 20. Guevara P, Rojas E, Gonzalez N, et al. Presence of Leishmania braziliensis in blood samples from cured patients of at different stages of immunotherapy. Clin Diag Laborat Immunol 1994;1:385-389.
21. 21. Walton BC, Valverde Chinel L, Eguia y Eguia O. Onset of espundia after many years of occult infection with Leishmania braziliensis. Am J Trop Med Hyg 1973;22:696-698.
22. 22. Hernandez D, Rodriguez N, Martinez C, et al. Leishmania braziliensis causing visceral leishmaniasis in a patient with human immunodeficiency virus infection, identified with the aid of the polymerase chain reaction. Trans R Soc Trop Med Hyg 1993;87:627-628.
23. 23. Machado E, Braga M, Da-Cruz AM, et al. Disseminated American muco-cutaneous leishmaniasis caused by Leishmania braziliensis braziliensis in a patient with AIDS: A case report. Mem Inst Oswaldo Cruz 1992;87:487-492.
24. 24. Rodriguez M. Health policy for leishmaniasis control: The experience of Peru in Leishmaniasis control strategies. IDCR-MP322e, Ottawa, Canada, 1992.
25. 25. Navin TR, Arana BA, Arana FE, et al. Placebo-controlled clinical trial of sodium stibogluconate (Pentostam) vs. ketoconazole for treating cutaneous leishmaniasis in Guatemala. J Infect Dis 1992;165:528-534.
26. 26. Davies CR, Llanos-Cuentas EA, Pyke SDM, et al. Cutaneous leishmaniasis in the Peruvian Andes: An epidemiological study of infection and immunity. Epidemiol Infect 1995;114:297-318.
27. 27. Weigle KA, Saravia NG, Davalos M, et al. Leishmania braziliensis from the Pacific Coast region of Colombia: Foci of transmission, clinical spectrum and isoenzyme phenotypes. Am J Trop Med Hyg 1986;35:722-731.
28. 28. Pimienta PFP, Turco SJ, McConville JJ, et al. Stage-specific adhesion of Leishmania promastigotes to the sandfly midgut. Science 1992;256:1812-1815.
29. 29. Theodos CM, Ribeiro JM, Titus RG. Analysis of enhancing effect of sand fly saliva on Leishmania infection in mice. Infect Immun 1991;59:1592-1598.
30. 30. Herwaldt B, Juranek D. Laboratory-acquired malaria, leishmaniasis, trypanosomiasis, and toxoplasmosis. Am J Trop Med Hyg 1993;48:313-323.
31. 31. Cohen C, Ciorazza F, Mol PD, et al. Leishmaniasis acquired in Belgium. Lancet 1991;338:128.
32. 32. Etoum I, Zilstra E, Ali M, et al. Congenital kala-azar and leishmaniasis in the placenta. Am J Trop Med Hyg 1992; 46:57-62.
33. 33. Martinez JE, Arias AL, Escobar MA, et al. Haemoculture of Leishmania (Viannia) braziliensis from two cases of mucosal leishmaniasis: Re-examination of haematogenous dissemination. Trans R Soc Trop Med Hyg 1992;86:392-394.
34. 34. Bowdre JH, Campbell JL, Walker D, et al. American mucocutaneous Leishmaniasis. Culture of a Leishmania species from peripheral blood leukocytes. Am J Clin Pathol 1981;75:435-438.
35. 35. Sanchez JL, Benedict M, Diniega BM, et al. Epidemiologic investigation of an outbreak of cutaneous leishmaniasis in a defined geographic focus of transmission. Am J Trop Med Hyg 1992;47:47-54.
36. 36. Gutierrez Y, Salinas GH, Palma G, et al. Correlation between histopathology, immune response, clinical presentation, and evolution in Leishmania braziliensis infection. Am J Trop Med Hyg 1991;45:281-289.
37. 37. Biddlestone LR, Hepburn NC, McLaren KM. A clinicopathological study of cutaneous leishmaniasis in British troops from Belize. Trans R Soc Trop Med Hyg 1994;88: 672-676.
38. 38. Hepburn NC, Tidman MJ, Hunter JAA. Cutaneous leishmaniasis in British troops from Belize. Br J Dermatol 1993;128:63-68.
39. 39. Beach R, Kiilu J, Leewenburg J. Modification of sandfly biting behavior by Leishmania leads to increased parasite transmission. Am J Trop Med Hyg 1985;34:278.
40. 40. Ridley DS, Marsden PD, Cuba CC, et al. A histological classification of cutaneous leishmaniasis and its geographical expression. Trans R Soc Trop Med Hyg 1980; 74:515-521.
41. 41. Bittencourt AL, Barral A. Evaluation of the histopathological classifications of American cutaneous and mucocutaneous leishmaniasis. Mem Inst Oswaldo Cruz 1991; 86:51-56.
42. 42. Rojas JI, Tani E, Orn A, et al. Leishmania (Viannia) panamensis-induced cutaneous leishmaniasis in Balb/c mice: pathology. Int J Exp Path 1993;74:481-491.
43. 43. Palma GI, Saravia NG. In situ characterization of the human host response to Leishmania panamensis (submitted).
44. 44. Weigle KA, Davalos M, Heredia P, et al. Diagnosis of cutaneous and mucocutaneous leishmaniasis in Colombia. A comparison of seven methods. Am J Trop Med Hyg 1987;36:489-496.
45. 45. Saravia NG, Weigle K, Segura I, et al. Recurrent lesions in human Leishmania braziliensis infection: Reactivation or reinfection? Lancet 1990;336:398-402.
46. 46. Marsden PD, Tada MS, Barreto AC, et al. Spontaneous healing of Leishmania braziliensis braziliensis skin ulcers. Trans R Soc Trop Med Hyg 1984;78:561-562.
47. 47. Saenz RE, Paz H, Berman JD. Efficacy of ketoconazole against Leishmania braziliensis panamensis cutaneous leishmaniasis. Am J Med 1990;89:147-155.
48. 48. Guderian RH, Chico ME, Rogers MD, et al. Placebo controlled treatment of Ecuadorian cutaneous leishmaniasis. Am J Trop Med Hyg 1991;45:92-97.
49. 49. Magill AJ. Epidemiology of the Leishmaniases. Dermatol Clin 1995;13:505-523.
50. 50. Goihman-Yahr M. American mucocutaneous Leishmaniasis. Dermatol Clin 1994;12:703-713.
51. 51. Weigle KA, Escobar M, Arias AL, et al. A clinical prediction rule for American cutaneous leishmaniasis in Colombia. Int J Epidem 1993;21:548-556.
52. 52. Bittencourt AL, Costa J, Carvalho EM, et al. Leishmaniasis recidiva cutis in American cutaneous leishmaniasis. Int J Dermatol 1993;32:802-805.
53. 53. Jones TC, Johnson WD, Barretto AC, et al. Epidemiology of American cutaneous leishmaniasis due to Leishmania braziliensis braziliensis. J Infect Dis 1987;156:73-83.
54. 54. Herwaldt BL, Berman JD. Recommendations for treating leishmaniasis with sodium stibogluconate (pentostam) and review of pertinent clinical studies. Am J Trop Med Hyg 1992;46:296-306.
55. 55. Ballou WR, McClain JB, Gordon DM, et al. Safety and efficacy of high-dose sodium stibogluconate therapy of American cutaneous leishmaniasis. Lancet 1987;13-16.
56. 56. Spier S, Medenica M, McMillan S, et al. Sporotrichoid leishmaniasis. Arch Dematol 1977;113:1104-1105.
57. 57. Floch H. Leishmania tropica guyanensis n.ss., agent da la leishmaniose tegumentaire des Guyanas et de l'Amerique Centrale. Arch Inst Pasteur Guyane Francaise 1954;15:1-4.
58. 58. Kostman JR, DiNubile MJ. Nodular lymphangitis: A distinctive but often unrecognized syndrome. Ann Int Med 1993;118:883-888.
59. 59. Barral A, Barral-Netto M, Almeida R, et al. Lymphadenopathy associated with Leishmania braziliensis cutaneous infection. Am J Trop Med Hyg 1992;47:587-592.
60. 60. Barral A, Guerreiro J, Bomfim G, et al. Lymphadenopathy as the first sign of human cutaneous infection by Leishmania braziliensis. Am J Trop Med Hyg 1995;53:256-259.
61. 61. Sousa A de Q, Parise ME, Pompeu MML, et al. Bubonic leishmaniasis: A common manifestation of Leishmania (Viannia) braziliensis infection in Ceara, Brazil. Am J Trop Med Hyg 1995;53:380-385.
62. 62. Travi BL, Rey-Ladino J, Saravia NG. Behavior of Leishmania braziliensis s.I in golden hamsters: Evolution of the infection under different experimental conditions. J Parasit 1988;74:1059-1062.
63. 63. Martinez JE, Travi BL, Valencia AZ, et al. Metastatic capability of Leishmania (Viannia) panamensis and Leishmania (Viannia) guyanensis in golden hamsters. J Parasit 1991;77:762-768.
64. 64. Berger T, Meltzer M, Oster CN. Lymph node involvement in leishmaniasis. J Am Acad Dermatol 1985;12:993-996.
65. 65. Costa JML, Marsden PD, Llanos-Cuentas EA, et al. Disseminated cutaneous leishmaniasis in a field clinic in Bahia, Brazil: A report of eight cases. J Trop Med Hyg 1986;89:319-323.
66. 66. Marsden PH. Mucosal leishmaniasis ("espundia" escomel, 1911). Trans R Soc Trop Med Hyg 1986;80:859-876.
67. 67. Saravia NG, Holguin AF, McMahon-Pratt D, et al. Mucocutaneous leishmaniasis in Colombia: Leishmania braziliensis subspecies diversity. Am J Trop Med Hyg 1985; 34:714-720.
68. 68. Convit J, Ulrich M, Fernandez CT, et al. The clinical and immunological spectrum of American cutaneous leishmaniasis. Trans Roy Soc Trop Med Hyg 1993;87:444-448.
69. 69. Marsden PD, Llanos-Cuentas EA, Lago EL, et al. Human mucocutaneous leishmaniasis in Tres Bracos, Bahia-Brazil. An area of Leishmania braziliensis braziliensis transmission. III. Mucosal disease presentation and initial evolution. Rev Soc Bras Med Trop 1984;17:179-186.
70. 70. Convit J, Pinardi ME, Rondon AJ. Diffuse cutaneous leishmaniasis: A disease due to an immunological defect of the host. Trans R Soc Trop Med Hyg 1972;66:603-610.
71. 71. Simpson MH, Mullins JF, Stone OJ. Disseminated anergic cutaneous leishmaniasis: An autochothonous case in Texas and the Mexican states of Tamaulipas and Nuevo Leon. Arch Dermat 1968;97:301-303.
72. 72. Bogaert-Diaz H, Riojas FR, De Leon A, et al. Leishmaniasis tegumentaria americana: Reporte de los primeros tres casos: forma anergica en tres hermanos". Rev Dominica Dermatol 1975;9:19-33.
73. 73. Andrade-Narvaez FJ, Simmonds-Diaz E, Rico-Aguilar S, et al. Incidence of localized cutaneous leishmaniasis (chichero's ulcer) in Mexico. Trans R Soc Trop Med Hyg 1990;84:219-220.
74. 74. Prata A, Piva N, Presenca de leishmanias em pele aparentemente norma de pacientes com calazar. O Hospital 1956;49:481-486.
75. 75. Oliveira Neto MP, Grimaldi Jr G, Momen H, et al. Active cutaneous leishmaniasis in Brazil, induced by Leishmania donovani chagasi. Mem Inst Oswaldo Cruz 1986;81:303-309.
76. 76. Gramiccia M, Gradoni L. Successful in vitro isolation and cultivation of Italian dermotropic strains of Leishmanai infantum sensu lato. Trans R Soc Trop Med Hyg 1989;83: 77-79.
77. 77. Ponce C, Ponce E, Morrison A, et al. Leishmania donovani chagasi: New clinical variant of cutaneous leishmaniasis in Honduras. Lancet 1991;337:67.
78. 78. Coura JR, Galvao-Castro B, Grimaldi Jr. G. Disseminated American cutaneous leishmaniasis in a patient with AIDS. Mem Inst Oswald Cruz 1987;82581-82582.
79. 79. Zeledon R, Hidalgo H, Viquez A, et al. Atypical cutaneous leishmaniasis in semiarid region of north-west Costa Rica. Trans R Soc Trop Med Hyg 1989;83:786.
80. 80. Neves J, Bezerra AA, Martins NRLL. Leishmaniose visceral associada a lesoes cutaneas. O Hospital 1963;63: 337-347.
81. 81. Badaro R, Jones TC, Lorenzo R, et al. A prospective study of visceral leishmaniasis in an endemic area of Brazil. J Infect Dis 1986;154:639-649.
82. 82. Schreck CE, Kline DL, Chaniotis BN, et al. Evaluation of personal protection methods against phlebotomine sand flies including vector of leishmaniasis in Panama. Am J Trop Med Hyg 1982;31:1046-1053.
83. 83. Evans TG, Teixeira MJ, McAuliffe IT, et al. Epidemiology of visceral leishmaniasis in northeast Brazil. J Infect Dis 1992;166:1124-1132.
84. 84. Wirtz RA, Rowton ED, Hallam JA, et al. Laboratory testing of repellents against the sandfly Phlebotomus papatasi (Diptera: Phsychodidae). J Med Entomol 1986;23:176-180.
85. 85. Dedet JP, Esterre P, Pradinaud R. Individual clothing prophylaxis of cutaneous leishmaniasis in the Amazonian area. Trans R Soc Trop Med Hyg 1987;81:748.
86. 86. Alexander B, Cadena H, Usma MC, et al. Laboratory and field evaluations of a repellent soap containing diethyl toluamide (DEET) and permethrin against phlebotomine sand flies (Diptera: Psychodidae) in Valle del Cauca, Colombia. Am J Trop Med Hyg 1995;52:169-173.
87. 87. Larsen CP, Steinman RM, Witmer-Pack M, et al. Migration and maturation of Langerhans cells in skin transplant and explants. J Exp Med 1990;172:1483-1493.
88. 88. Blank C, Fuchs H, Rappersberg K, et al. Parasitism of epidermal Langerhans cells in experimental cutaneous leishmaniasis with Leishmania major. J Infect Dis 1993;167: 418-425.
89. 89. Moll H, Fuchs H, Blank C, et al. Langerhans cells transport Leishmania major from the infected skin to the draining lymph node for presentation to antigen-specific T cells. Eur J Immunol 1993;23:1595-1601.
90. 90. Fillola G, Corberand JX, Laharrague PF, et al. Peripheral intramonocytic Leishmanias in an AIDS patient. J Clin Microbiol 1992;30:3284-3285.
91. 91. Nuwayri-Salti N, Muatassem D, Salman S, et al. Chronic cutaneous leishmaniasis: Leishmania parasites in blood. Int J Dermatol 1992;31:562.
92. 92. Magill AJ, Grog M, Gasser Jr, R et al. Visceral infection caused by Leishmania tropica in veterans of Operation Desert Strom. N Engl J Med 1993;328:1383-1387.
93. 93. Knowles R, Das Gupta M. The diagnosis of kala azar by examination of thick blood films. Indian Med Gazette 1924;59:438-440.
94. 94. Chulay JD, Adoyo MA, Githore JJ. Leishmania donovani parasitaemia in Kenyan visceral leishmaniasis. Trans R Soc Trop Med Hyg 1985;79:218-222.
95. 95. Long PI. Cutaneous leishmaniasis treated with metronidazole. J Am Med Assoc 1973;223:1378-1379.
96. 96. Shaw PK, Quigg LT, Allain DS, et al. Autochthonous dermal leishmaniasis in Texas. Am J Trop Med Hyg 1976;25:788-796.
97. 97. White SW, Hendricks LD. American cutaneous leishmaniasis. Int J Dermatol 1982;21:86-88.
98. 98. Walton BC. American cutaneous and mucocutaneous leishmaniasis. In The Leighmaniases in Biology and Medicine. Vol. II Ed. W. Peters and R. Killick-Kendrick. 1987. pp 638-664.
99. 99. Rab MB, Hassan M, Bux D, et al. The isolation and cultivation of Leishmania infantum from apparently normal skin of visceral leishmaniasis patients in northern Pakistan. Trans R Trop Med Hyg 1992;86:620-621.
100. 100. Bertho A, Santiago M, Coutinhos S. An experimental model of the production of metastases in murine cutaneous leishmaniasis. J Parasitol 1994;80:93-99.
101. 101. Travi BL, Osorio Y, Saravia NG. The inflammatory response promotes cutaneous metastasis in hamsters infected with Leishmania (Viannia) panamensis. J Parasitol 1996;82:454-45.
102. 102. Barker JWN, Mitra RS, Griffiths CEM, et al. Keratinocytes as initiators of inflammation. Lancet 1991;337:211-214.
103. 103. Mirckovich GF, Galelli A, Allison AC, et al. Increased myelopoiesis during L. major infection on mice: Generation of "safe target," a possible way to evade the effector immune mechanism. Clin Exp Immunol 1986;64:1-6.
104. 104. Leon LL, Machado GMC, Barral A, et al. Antigenic differences among Leishmania amazonensis isolates and their relationship with distinct clinical forms of the disease. Mem Inst Oswaldo Cruz 1992;87:229-234.
105. 105. Convit J, Castellanos PL, Ulrich M, et al. Immunotherapy of localized, intermediate, and diffuse forms of American cutaneous leishmaniasis. J Infect Dis 1989;160:104-115.
106. 106. Peterson EA, Neva FA, Barral A, et al. Monocyte suppression of antigen-specific lymphocyte responses in diffuse cutaneous leishmaniasis patients from the Dominican Republic. J Immunol 1984;132:2603-2606.
107. 107. Saravia NG, Valderrama L, Labrada M, et al. The relationship of Leishmania braziliensis subspecies and immune response to disease expression in New World leishmaniasis. J Infect Dis 1989;159:725-735.
108. 108. Walton BC, Valverde L. Racial differences in espundia. Am Trop Med Parasitol 1979;73:23-29.
109. 109. Cuba CC, Barreto AC, Llanos-Cuentas AE, et al. Human mucocutaneous leishmaniasis in Tres Bracos, Bahia-Brazil. An area of Leishmania braziliensis transmission. I. Laboratory diagnosis. Revista da Sociedade Brasileira de Med Trop 1984;17:161-167.
110. 110. Robledo S, Worsencraft A, Valencia AZ, et al. Human monocyte infection by Leishmania (Viannia) panamensis: A role of complement receptors and correlation of susceptibility in vitro with clinical phenotype. J Immunol 1994; 152:1265-1275.
111. 111. Melby PC, Andrade-Narvaez FJ, Darnell BJ, et al. Increased expression of proinflammatory cytokines in chronic lesions of human cutaneous leishmaniasis. Infec Immun 1994;62:837-842.
112. 112. Pirmez C, Yamamura M, Uyemura K, et al. Cytokine patterns in the pathogenesis of human leishmaniasis. Am Soc Clinical Invest 1993;91:1390-1395.
113. 113. Nabors GS, Afonso LCC, Farrel JC, et al. A switch from a type 2 to a type 1 helper response and cure of established Leishmania major infection in mice is induced by combined therapy with interleukin-12 and pentostam. Proc Nat Acad Sci USA 1995 (in press).
114. 114. Berhe N, Hailu A, Gemetchu T. Human immunodeficiency virus and recurrence of cutaneous leishmaniasis long after healed localized cutaneous leishmaniasis due to Leishmania aethiopica. Trans R Soc Trop Med Hyg 1995; 89:400-101.
115. 115. Rocha RAA, Sampaio RN, Guerra M, et al. Apparent Glucantime failure in five patients with mucocutaneous leishmaniasis. J Trop Med Hyg 1980;83:131-139.
116. 116. Escobar MA, Saravia NG, Weigle K. Concurrent mucosal leishmaniasis and pulmonary tuberculosis: two case reports and review. J Clin Infect Dis (in press).
117. 117. Golino A, Duncan J, Zeluff B, et al. Leishmaniasis in a heart transplant patient. J Heart Lung Trans 1992;11:820.
118. 118. Bradley DM, Kirkley J. Variation in susceptibility of mouse strains to Leishmania donovani infection. Trans R Soc Trop Med Hyg 1972;66:527-528.
119. 119. Bradley DJ. Genetic control of natural resistance to L. donovani. Nature 1974;250:353-354.
120. 120. Perez H, Labrador F, Torrealba JW. Variation in the response of five strains of mice to Leishmania mexicana. Int J Parasitol 1979;9:27-32.
121. 121. Handman E, Ceredig R, Mitchel GF. Murine cutaneous leishmaniasis: Disease patterns in intact and nude mice of various gentypes and examination of some differences between normal and infected macrophages. Aust J Expo Bil Med Sci 1979;57:9-29.
122. 122. Howard JG, Hale C, Chan-Liew WL. Immunological regulation of experimental cutaneous leishmaniasis. I. Immunogenetic aspects of susceptibility to Leishmania tropica in mice. Parasite Immunol 1980a;2:303-314.
123. 123. Merino F, Biondo M, Rodriguez F. Análisis de la susceptibilidad genética de ratones a la infección por Leishmania mexicana amazonensis. Immunol 1983;2:135-137.
124. 124. Behin R, Mauel J, Sordat B. Leishmania tropica: pathogenicity and in vitro macrophage function in strains of inbred mice. Expl Parasit 1979;48:81-91.
125. + T lymphocytes. Cell Immun 1982;67:74-89.
126. 126. Mock BA, Fortier AH, Potter M, et al. Genetic control of systemic Leishmania major infections: Dissociation of intrahepatic amastigote replication from control by Lsh gene. Inf Immun 1985;50:588-591.
127. 127. Crocker PR, Davies EVE, Blackwell JM. Variable expression of the murine natural resistance gene Lsh in different macrophage populations infected in vitro with Leishmania donovania. Parasite Immun 1987;9:705-719.
128. 128. Davies EV, Singleton AMT, Blackwell JM. Differences in Lsh gene control over systemic Leishmania donovani or Leishmania mexicana infections are caused by differential targeting to infiltrating and resident liver macrophage populations. Infect Immun 1988;56:1128-1134.
129. 129. Scott P. The role of Thq and Th2 cell in experimental cutaneous leishmaniasis. Exp Parasitol 1989;63:369-372.
130. 130. Howard JG, Hale C, Chan-Liew WL. Genetically determined susceptibility to Leishmania tropica infection is expressed by haematopoietic dono cells in mouse radiation chimaeras. Nature 1980b;288:161-162.
131. 131. Roberts M, Alexander J, Blackwell J. Influence of Lsh, H-2 and H-11 linked gene on visceralization and metastasis associated with Leishmania mexicana infection in mice. Infect Immun 1989;57:875-881.
132. 132. Lara ML, Layrisse A, Scorza JV, et al. Immunogenetics of human American cutaneous leishmaniasis. Study of HLA haplotypes in 24 families from Venezuela. Hum Immunol 1991;30:129-135.
133. 133. Petzl-Erler ML, Belich MP, Queiroz-Tellez F. Association of mucosal leishmaniasis with HLA. Hum Immunol 1991;32:254-260.
134. 134. Fine PEM. Immunogenetics of susceptibility to leprosy, tuberculosis and leishmaniasis. An epidemiology perspective. Int J Leprosy 1981;49:437-454.
135. 135. Sanchez JL, Diniega BM, Small JW, et al. Epidemiologic investigation of an outbreak of cutaneous leishmaniasis in a defined geographic focus of transmission. Am J Trop Med Hyg 1992;47:47-54.
136. 136. Herrer A, Christensen HA. Epidemiological patterns of cutaneous leishmaniasis in Panama. I. Epidemics among small groups of settlers. Ann Trop Med Parasitol 1976; 70:59-65.
137. 137. Lainson R, Strangeways-Dixon J. Leishmania mexicana: The Epidemiology of dermal leishmaniasis in British Honduras. Trans R Soc Trop Med Hyg 1963;57:242-265.
138. 138. Adler S, Gunders AE. Immunity to Leishmania mexicana following spontaneous recovery from oriental sore. Trans R Soc Trop Med Hyg 1964;58:274-277.
139. 139. Lainson R, Shaw JJ. Studies on the immunology and serology of leishmaniasis and Leishmania. III. On the cross-immunity between Panamanian cutaneous leishmaniasis and Leishmania mexicana infection in man. Trans R Soc Trop Med Hyg 1966;60:533-535.
140. 140. Kreutzer RD, Grogl M, Neva FA, et al. Identification and genetic comparison of Leishmania parasites causing viscerotropic and cutaneous disease in soldiers returning from Operation Desert Strom. Am J Trop Med Hyg 1993; 49:357-363.
141. 141. Neal RA, Hale C. A comparative study of the susceptibility of inbred and outbred mouse strains compared with hamsters to infection with New World cutaneous leishmaniasis. Parasitology 1983;87:7.
142. 142. Childs GE, Lightner LK, McKinney L. et al. Inbred mice as model hosts for cutaneous leishmaniasis. Ann Trop Med Parasitol 1984;78:25-34.
143. 143. Wilson HR, et al. Leishmania braziliensis and Leishmania mexicana: Experimental cutaneous infections in golden hamsters. Exp Parasitol 1979;47:270-283.
144. 144. Giannini MS. Effects of promastigote growth phase, frequency of subculture, and host age on promastigoteinitiated infections with Leishmania donovani in the golden hamster. J Protozool 1974;21:521-527.
145. 145. Sacks DL. Metacyclogenesis in Leishmania promastigotes. Exp Parasitol 1989;69:100-103.
146. 146. Rey LJ, Travi B, Valencia AZ, et al. Infectivity of the subspecies of the L. braziliensis complex in vivo and in vitro. Am J Trop Med Hyg 1990;43:623-631.
147. 147. Sacks DL, Da Silva RP. The generation of infective stage Leishmania major promastigotes is associated with cell-surface expression and release of a developmentally regulated glycolipid. J Immunol 1987;139:3099-3106.
148. 148. Handman E, Schnur LF, Spithill TW, et al. Passive transfer of Leishmania lipophosphoglycan confers parasite survival in macrophages. J Immunol 1986;137:3608-3614.
149. 149. McNeely TB, Turco SJ. Requirement of lipophosphoglycan for intracellular survival of Leishmania donovani within human monocytes. J Immunol 1990;144:2745-2750.
150. 150. McConville MJ, Homans SW. Identification of the defect in lipophosphoglycan biosynthesis in a non-pathogenic strain of Leishmania major. J Biol Chem 1992;267:58551-58561.
151. 151. Descoteaux A, Turco S, Sacks DL, et al. Leishmania donovani lipophosphoglycan selectively inhibits signal transduction in macrophages. J Immunol 1991;146:2747-2753.
152. 152. Descoteaux A, Matlasehwski G, Turco SJ. Inhibition of macrophage protein kinase C-mediated protein phosphorylation by Leishmania donovani lipophosphoglycan. J Immunol 1992;149:3008-3015.
153. 153. Pimienta PFP, Saraiva EMB, Rowton E, et al. Evidence that the vectorial competence of phlebotomine sand flies for different species of Leishmania is controlled by structural polymorphisms in the surface lipophosphoglycan. Proc Nat Acad Sci USA 1994;91:9155-9159.
154. 154. Ilg T, Etges R, Overath P, et al. Structure of Leishmania mexicana lipophosphoglycan. J Biol Chem 1992;267:6834-6840.
155. 155. Brittingham A, Morrison CJ, McMaster R, et al. Role of the Leishmania surface protease gp63 in complement fixation, cell adhesion, and resistance to complement-mediated lysis. J Immunol 1995;155:3102-3111.
156. 156. Kweider M, Lemesre JL, Daray F, et al. Infectivity of Leishmania braziliensis promastigotes is dependent on the increasing expression of a 65000-dalton surface antigen. J Immunol 1987;138:299-305.
157. 157. Russell DG. The macrophage-attachment glycoprotein gp63 is the predominant 3-acceptor site on Leishmania mexicana promastigotes. Eur J Biochem 1987;164:213-221.
158. 158. Puentes SM, Sacks DL, Da Silva RP, et al. Complement binding by two developmental stages of Leishmania major promastigotes varying in expression of a surface lipophosphoglycan. J Ex Med 1988;167:887-902.
159. 159. Kelleher M, Bacic A, Handman E. Identification of a macrophage-binding determinant on lipophosphoglycan from Leishmania major promastigotes. Proc Nat Acad Sci USA 1992;89:6-10.
160. 160. Rusell DG, Wilhelm H. The involvement of the major surface glycoprotein (gp63) of Leishmania promastigotes in attachment to macrophages. J Immunol 1986;136: 2613-2620.
161. 161. Murray PJ, Handman E, Glaser TA, et al. Leishmaniasis major: Expression and gene structure of the glycoprotein 63 molecule in virulent and avirulent clones and strains. Expo Parasitol 1990;71:294-304.